Isolated Cervical Tuberculosis in Patients with HIV Infection

Abstract

OBJECTIVE: Tuberculosis isolated to the head and neck region is common in patients with HIV infection. However, the management of isolated head and neck tuberculosis has not been reported in the literature. This study was done to describe the characteristics of tuberculosis isolated to the head and neck region in patients infected with HIV and to detect differences in presentation and diagnostic management based on the status of HIV infection at presentation.

METHODS: A retrospective study was performed including 38 patients infected with HIV who were seen with tuberculosis isolated to the head and neck region at two tertiary care centers during a 10-year period. These patients were divided into two groups on the basis of the HIV status at presentation, which indirectly reflects the level of immunosuppression. Group 1 included 11 patients (29%) with AIDS at presentation. Group 2 included 27 patients (71%) with HIV infection but not AIDS.

RESULTS: The cervical lymphatics were the most common site for isolated head and neck tuberculosis (89%), with the supraclavicular nodes most often involved (53%). Extralymphatic involvement was less common (11%), but involved a variety of anatomic locations (skin, spinal cord, larynx, parotid). The presenting history and physical examination had a low sensitivity for tuberculosis in patients with HIV infection, mainly because of the presence of multiple confounding factors. Purified protein derivative testing was highly sensitive for tuberculosis in patients with HIV infection alone (61%); however, its usefulness was diminished in patients with AIDS (14%; p = 0.03). Fine-needle aspiration biopsy was 94% sensitive for diagnosing tuberculosis and was not affected by the status of HIV infection. Surgical biopsy was the gold standard for diagnosing tuberculosis but was associated with chronically draining fistulas in a significant number of cases (14%).

CONCLUSIONS: These data suggest that tuberculosis should be considered in the differential diagnosis of all head and neck lesions in patients infected with HIV, even in the absence of pulmonary involvement. Purified protein derivative testing should be done liberally in these patients, with realization that the sensitivity of purified protein derivative testing is reduced in patients with AIDS. Fine-needle aspiration biopsy should be the key diagnostic test in this patient population, with open surgical biopsy reserved for highly suspicious cases in which other measures were not diagnostic. (Otolaryngol Head Neck Surg 1998;118:766-70.)

Get full access to this article

View all access options for this article.

References

1. Steele

Ranny

AF.

Animal tuberculosis. Am Rev Tuberculosis 1958; 77:908–22.

2. Bates

Stead

WW.

The history of tuberculosis as a global epidemic. Med Clin North Am 1993; 77:1205–17.

3. Diamond

JM.

The arrow of disease. Discover 1992; 13:64–9.

4. Dubos

Dubos

The white plague. New Brunswick, New Jersey: Rutgers University Press; 1987. p. 277.

5. Bloom

Murray

JL.

Tuberculosis: commentary on a re-emergent killer. Science 1992; 257:1055–64.

6. Peloguin

CA.

Pharmacology of the antimycobacterial drugs. Med Clin North Am 1993; 77:1253–62.

7. Pust

RE.

Tuberculosis in the 1990s: resurgence, regimens, and resources. South Med J 1992; 85:584–92.

8. Given

Khan

Reichman

LB.

Tuberculosis among patients with AIDS and a control group in the inner city community. Arch Intern Med 1994; 154:640–5.

9. Sundaram

McDonald

Maniatis

Oleske

Kapila

Reichman

LB.

Tuberculosis as a manifestation of the acquired immunodeficiency syndrome (AIDS). JAMA 1986; 256:362–6.

10.

10. Chaisson

Schecter

Theuer

Rutherford

Echenberg

Hopewell

PC.

Tuberculosis in patients with the acquired immunodeficiency syndrome: clinical features, response to therapy and survival. Am Rev Respir Dis 1987; 136:570–4.

11.

11. Tuberculosis and the acquired immunodeficiency syndrome: New York City. MMWR Morb Mortal Wkly Rep 1987; 36:785–95.

12.

12. Ellner

JJ.

Tuberculosis in the time of AIDS: the facts and the message. Chest 1990; 98:1051–2.

13.

13. Centers for Disease Control. Nosocomial transmission of multidrug-resistant tuberculosis among HIV infected persons: Florida and New York, 1988–1991. MMWR Morb Mortal Wkly Rep 1991; 40:585–91.

14.

14. Pitchenik

Burr

Saurez

Fertel

Gonzalez

Moas

Human T-cell lymphotrophic virus-III (HTLV-III) seropositivity and related diseases among 71 consecutive patients in whom tuberculosis was diagnosed. Am Rev Respir Dis 1987; 135:875–9.

15.

15. Reider

Cauthen

Bloch

Tuberculosis and acquired immunodeficiency syndrome: Florida. Arch Intern Med 1989; 149:1268–73.

16.

16. Pitchenik

Fertel

Block

AB.

Mycobacterial disease: epidemiology, diagnosis, treatment and prevention. Clin Chest Med 1988; 9:425–41.

17.

17. Selwyn

Hartel

Lewis

VA.

A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med 1989; 320:545–50.

18.

18. Beck

Mycobacterial disease associated with HIV infection. J Gen Intern Med 1991; 6(suppl):S19-–23.

19.

19. Pitchenik

Rubinson

The radiographic appearance of tuberculosis in patients with acquired immunodeficiency syndrome (AIDS) and pre-AIDS. Am Rev Respir Dis 1985; 131:393–6.

20.

20. Hooper

AA.

Tuberculous peripheral lymphadenitis. Br J Surg 1972; 59:353–9.

21.

21. Subrahmanyam

Role of surgery and chemotherapy for peripheral lymph node tuberculosis. Br J Surg 1993; 80:1547–8.

22.

22. Singh

Balwally

Nash

Har-El

Lucente

FE.

Laryngeal tuberculosis in HIV infected patients: a difficult diagnosis. Laryngoscope 1996; 106:1238–40.

23.

23. Centers for Disease Control. Purified protein derivative (PPD): tuberculin anergy and HIV infection—guidelines for anergy testing and management of anergic individuals at risk for tuberculosis. Immunol Allergy Pract 1994; 16:38–42.

24.

24. Holden

Dubin

Diamond

PH.

Frequency of negative intermediate-strength tuberculin sensitivity in patients with active tuberculosis. N Engl J Med 1971; 285:1506–9.

25.

25. Long

Maycher

Scalcini

Manfreda

The chest roentgenogram in pulmonary tuberculosis patients seropositive for human immunodeficiency virus type-1. Chest 1991; 99:123–7.

26.

26. Dooley

Castro

Hutton

Mullan

Polder

Snider

DE.

Guidelines for preventing the transmission of tuberculosis in health-care settings, with special focus on HIV-related issues. MMWR Morb Mortal Wkly Rep 1990; 39(RR-17):1–30.

27.

27. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 1986; 134:355–63.

28.

28. Centers for Disease Control. The use of preventative therapy for tuberculosis infection in the United States: recommendations of the advisory committee for the elimination of tuberculosis. MMWR Morb Mortal Wkly Rep 1990; 39:9–12.

29.

29. Barnes

Davidson

PT.

Tuberculosis in patients with HIV infection. Med Clin North Am 1993; 77:1369–90.

30.

30. Centers for Disease Control. National action plan to combat multidrug-resistant tuberculosis: meeting the challenge of multidrug-resistant tuberculosis. Summary of a conference: management of persons exposed to multidrug-resistant tuberculosis. MMWR Morb Mortal Wkly Rep 1992; 41(RR-11):1–71.

31.

31. Barnes

Bloch

Davidson

Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991; 324:1645–50.

32.

32. Fischl

Daikos

Uttamchandani

Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli. Ann Intern Med 1992; 117:184–90.